Overview of Dr. Garcia-Aguilar
Dr. Julio Garcia-Aguilar is a colorectal surgeon in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Complutense University of Madrid and has been in practice 38 years. Dr. Garcia-Aguilar accepts several types of health insurance, listed below. He is one of 12 doctors at Memorial Sloan Kettering Cancer Center and one of 3 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Colon & Rectal Surgery. He also speaks multiple languages, including Spanish. He has more than 100 publications and over 500 citings.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
University of MinnesotaResidency, Colon and Rectal Surgery, 1992 - 1993
Beth Israel Deaconess Medical CenterResidency, Surgery, 1985 - 1986
Complutense University of MadridClass of 1979
Certifications & Licensure
CA State Medical License 2002 - Present
FL State Medical License 2023 - Present
NY State Medical License 2012 - 2026
NJ State Medical License 2021 - 2025
MN State Medical License 1993 - 2003- American Board of Colon and Rectal Surgery Colon & Rectal Surgery
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer Start of enrollment: 2006 May 01
- Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer Start of enrollment: 2008 Aug 01
- Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- 334 citationsAssessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant TherapyJ. Joshua Smith, Paul Strombom, Oliver S. Chow, Campbell S.D. Roxburgh, Patricio B. Lynn
JAMA Oncology. 2019-04-01 - 125 citationsExtended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation.Christian P. Probst, Adan Z. Becerra, Christopher T. Aquina, Mohamedtaki Abdulaziz Tejani, Steven D. Wexner
Journal of the American College of Surgeons. 2015-08-01 - 1 citationsChemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 a...Emmanouil Fokas, Hannah Williams, Markus Diefenhardt, Sabrina Lin, Li-Xuan Qin
European Journal of Cancer. 2024-10-01
Press Mentions
Restaging MRI in Rectal Cancer Patients Helps Predict OutcomesSeptember 3rd, 2024
Clinical Controversy: Watch-and-Wait or Surgery in Rectal Cancer near Complete Responders?August 20th, 2024- Treating Rectal Cancer: PROSPECT, PRODIGE, or OPRA?July 12th, 2023
Grant Support
- Timing Of Rectal Cancer Response To ChemoradiationNational Cancer Institute2008–2009
- Timing Of Rectal Cancer Response To ChemoradiationNational Cancer Institute2003–2007
Professional Memberships
- Member
Other Languages
- Spanish
Insurance Accepted
- BCBS Blue Card PPO
BCBS California CaliforniaCare HMO
BCBS California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOGreat West PPO
Health Net California Large Group PPO
Pacificare HMO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
